Panel discussion “Clinical Trails into the Future” from the 2023 Utah Life Sciences Summit presented by BioUtah on November 9, 2023. Panelists included Michelle Comas, chief regulatory officer of Signpath Pharma; Hollie DeSmet, CEO of HJD Consulting; Neeraj Rama, chief investment officer of CBCC Global; and Erika Keith, director of business development of Curabit.